Differential immunoscreening identifies a glycosylation variant of the epidermal growth factor receptor in ME-180 cervical carcinoma cells

Hybridoma

Volumn 24, Issue 5, 2005, Pages 225-230

  Hsu, Yi Te ^a   Hou, Qi ^a   Zhou, Hui ^a   Mohanty, Sangeeta ^a   Litvinchuk, Alexandra ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; CETUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; GLYCOSIDASE; MATUZUMAB; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 6C7; PANITUMUMAB; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN BINDING; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; DRUG PROTEIN BINDING; DRUG SPECIFICITY; DRUG SYNTHESIS; GLYCOSYLATION; HELA CELL; HUMAN; HUMAN CELL; IMMUNOAFFINITY CHROMATOGRAPHY; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEQUENCE ANALYSIS; UTERINE CERVIX CARCINOMA; UTERINE CERVIX EPITHELIUM; WESTERN BLOTTING;

ANIMALIA;

EID: 27144504400     PISSN: 15540014     EISSN: None     Source Type: Journal    
DOI: 10.1089/hyb.2005.24.225     Document Type: Article

References (13)

1. Yarden Y: The EGFR family and its ligands in human cancer. Signalling mechanisms and therapeutic opportunities. Eur J Cancer 2001;37:S3-S8.
2. Herbst RS, and Shin DM: Monoclonal antibodies to target epidermal growth factor receptor-positive tumors: a new paradigm for cancer therapy. Cancer 2002;94:1593-1611.
3. Ritter CA, and Arteaga CL: The epidermal growth factor receptor-tyrosine kinase: a promising therapeutic target in solid tumors. Semin Oncol 2003;30:3-11.
4. El-Rayes BF, and LoRusso PM: Targeting the epidermal growth factor receptor. Br J Cancer 2004;91:418-424.
5. Mathur SP, Mathur RS, Rust PF, and Young RC: Human papilloma virus (HPV)-E6/E7 and epidermal growth factor receptor (EGF-R) protein levels in cervical cancer and cervical intraepithelial neoplasia (CIN). Am J Reprod Immunol 2001;46:280-287.
6. Hsu Y-T, and Youle RJ: Nonionic detergents induce dimerization among members of the Bcl-2 family. J Biol Chem 1997;272: 13829-13834.
7. Hsu Y-T, and Youle RJ: Bax in murine thymus is a soluble monomeric protein that displays differential detergent-induced conformations. J Biol Chem 1998;273:10777-10783.
8. Hsu YT, Mohanty S, Litvinchuk A, and Hou Q: Generation and characterization of monoclonal antibodies directed against the surface antigens of cervical cancer cells. Hybrid Hybridomics 2004; 23:121-125.
9. Chinkers M, and Brugge JS: Characterization of structural domains of the human epidermal growth factor receptor obtained by partial proteolysis. J Biol Chem 1984;259:11534-11542.
10. Soderquist AM, and Carpenter G: Glycosylation of the epidermal growth factor receptor in A-431 cells. The contribution of carbohydrate to receptor function. J Biol Chem 1984;259:12586-12594.
11. Slieker LJ, and Lane MD: Post-translational processing of the epidermal growth factor receptor. Glycosylation-dependent acquisition of ligand-binding capacity. J Biol Chem 1985;260:687-690.
12. Ciardiello F, and Tortora G: A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor. Clin Cancer Res 2001;7:2958-2970.
13. Mendelsohn J: Epidermal growth factor receptor inhibition by a monoclonal antibody as anticancer therapy. Clin Cancer Res 1997; 3:2703-2707.